It has been reported that DIRAS3 is down‐regulated in glioma samples, and DIRAS3 overexpression inhibits the proliferation, migration and invasion of glioma cells.30 Instead, another study has shown that DIRAS3 is overexpressed in glioma and is positively associated with adverse outcome of glioma patients. This evidence concerns the gene DIRAS3 and central nervous system cancer.